Meaning and Significance of "Alkalization Therapy for Cancer"

被引:15
|
作者
Wada, Hiromi [1 ]
Hamaguchi, Reo [1 ]
Narui, Ryoko [1 ]
Morikawa, Hiromasa [1 ]
机构
[1] Japanese Soc Inflammat & Metab Canc, Kyoto, Japan
来源
FRONTIERS IN ONCOLOGY | 2022年 / 12卷
关键词
cancer; metabolism; tumor microenvironment; alkalization therapy; urine pH; bicarbonate; PROTON PUMP INHIBITORS; PANCREATIC-CANCER; TUMOR ACIDITY; PH DYNAMICS; MICROBIOME; CELLS; PARTHENOLIDE; METABOLISM; ACTIVATION; EXPRESSION;
D O I
10.3389/fonc.2022.920843
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives of the StudyOur research aims to answer the following questions. Can cancer progression be stopped by changing the body condition of person with cancer? Can cancer be cured?If cancer progression can be stopped, what is the underlying mechanism? Theoretical Rationale for Alkalization TherapyAlmost 70 years ago, Goldblatt H. & Cameron G. reported on the idea of alkalization therapy. Before that, Otto Warburg had been studying the metabolism of cancer and had discovered the essential nature of cancer. He published a review in Science in 1956 under the title "On the origin of cancer cells". From his phenomena described above, we established the theoretical rationale for alkalization therapy, based on the question of "How does cancer form and what is its nature"? Limitations of Deductive Methods and Inductive ApproachesIn this paper, we describe a method to reconstruct the limitations and weaknesses of modern cancer medicine as Science-based Medicine using an inductive method, and to present a new vision of cancer therapy. How should we treat cancer? (Case presentation): Using a specific clinical case, we present patients in whom were successfully treated with no or few anticancer drugs. The biggest weakness of current cancer treatments is that they only treat the cancer and not the actual patient. The "alkalization therapy" that we advocate does not compete with any of the current standard treatments, but improves the effectiveness of standard treatments, reduces side effects, and lowers medical costs.
引用
收藏
页数:17
相关论文
共 50 条
  • [21] Proline Oxidase (POX) as A Target for Cancer Therapy
    Kononczuk, Joanna
    Czyzewska, Urszula
    Moczydlowska, Joanna
    Surazynski, Arkadiusz
    Palka, Jerzy
    Miltyk, Wojciech
    CURRENT DRUG TARGETS, 2015, 16 (13) : 1464 - 1469
  • [22] Microfluidics as an Enabling Technology for Personalized Cancer Therapy
    Mathur, Lukas
    Ballinger, Martine
    Utharala, Ramesh
    Merten, Christoph A.
    SMALL, 2020, 16 (09)
  • [23] Clinical Significance of Simultaneous Determination of Serum Tryptophan and Tyrosine in Patients With Lung Cancer
    Ren, Ya-Ping
    Tang, Ai-Guo
    Zhou, Qian-Xuan
    Xiang, Zhong-Yuan
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2011, 25 (04) : 246 - 250
  • [24] Mitochondrial uncoupling protein 2 expression in colon cancer and its clinical significance
    Kuai, Xiao-Yi
    Ji, Ze-Yu
    Zhang, Hong-Jie
    WORLD JOURNAL OF GASTROENTEROLOGY, 2010, 16 (45) : 5773 - 5778
  • [25] Barriers and opportunities for gemcitabine in pancreatic cancer therapy
    Beutel, Alica K.
    Halbrook, Christopher J.
    AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2023, 324 (02): : C540 - C552
  • [26] The Role of Signaling Pathways in Pancreatic Cancer Targeted Therapy
    Zhuo, Fangfang
    Luo, Shuang
    He, Wei
    Feng, Zhanhui
    Hu, Ya'nan
    Xu, Jingxia
    Wang, Zejun
    Xu, Jianwei
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2023, 46 (03): : 121 - 128
  • [27] Circadian immunometabolism: A future insight for targeted therapy in cancer
    Tomar, Manendra Singh
    Mohit
    Kumar, Ashok
    Shrivastava, Ashutosh
    SLEEP MEDICINE REVIEWS, 2025, 80
  • [28] Mitochondria targeted fluorogenic theranostic agents for cancer therapy
    Singh, Hardev
    Sareen, Divya
    George, Jiya Mary
    Bhardwaj, Vineet
    Rha, Saehee
    Lee, Suk Joong
    Sharma, Sheetal
    Sharma, Amit
    Kim, Jong Seung
    COORDINATION CHEMISTRY REVIEWS, 2022, 452
  • [29] Progress in the research of cuproptosis and possible targets for cancer therapy
    Wang, Jiang
    Luo, Lan-Zhu
    Liang, Dao-Miao
    Guo, Chao
    Huang, Zhi-Hong
    Sun, Guo-Ying
    Wen, Jie
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2023, 14 (09): : 324 - 334
  • [30] Role of the microbiome in oral cancer occurrence, progression and therapy
    Li, Zhengrui
    Liu, Yuan
    Zhang, Ling
    MICROBIAL PATHOGENESIS, 2022, 169